Alternative Data for Abbott Laboratories
About Abbott Laboratories
Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.
| Price | $108.27 |
| Target Price | Sign up |
| Volume | 16,540,000 |
| Market Cap | $187B |
| Year Range | $107.42 - $136.15 |
| Dividend Yield | 2.21% |
| PE Ratio | 28.88 |
| Analyst Rating | 87% buy |
| Industry | Health Care Services |
In the news
 |
Evercore ISI Says Abbott’s (ABT) Core Growth Drivers Are Still IntactJanuary 26 - Yahoo |
|
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on ItJanuary 25 - Yahoo |
 |
Abbott Laboratories: Double-Digit Earnings Growth Makes It A BuyJanuary 24 - SeekingAlpha |
 |
Abbott Laboratories: The Market's Overreaction Is The Long-Term Investor's OpportunityJanuary 23 - SeekingAlpha |
|
Assessing Abbott Laboratories (ABT) Valuation After Q4 2025 Earnings Miss And Softer 2026 GuidanceJanuary 23 - Yahoo |
|
Abbott Laboratories Expects H2 Growth Driven by Product Launches, Nutrition Recovery, RBC SaysJanuary 23 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '25 | 11.5B | 4.92B | 6.54B | 1.78B | 2.52B | 1.500 |
| Q3 '25 | 11.4B | 5.03B | 6.34B | 1.64B | 3.09B | 1.300 |
| Q2 '25 | 11.1B | 4.85B | 6.29B | 1.78B | 3.05B | 1.260 |
| Q1 '25 | 10.4B | 4.91B | 5.44B | 1.33B | 2.67B | 1.090 |
| Q4 '24 | 11B | 5.38B | 5.6B | 9.23B | 2.99B | 1.340 |
Insider Transactions View All
| Ford Robert B filed to buy 216,203 shares at $107.1. January 26 '26 |
| Shroff Eric filed to sell 30,384 shares at $128. November 25 '25 |
| Boudreau Philip P filed to sell 51,003 shares at $134.6. August 11 '25 |
| Blount Sally E. filed to sell 34,058 shares at $129.7. May 2 '25 |
| Earnhardt Lisa D filed to sell 71,928 shares at $136.6. March 7 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Julie Johnson |
Jan 16, 26 | Sell | $1K - $15K |
| Julia Letlow |
Jan 14, 26 | Sell | $1K - $15K |
| Julia Letlow |
Jan 14, 26 | Buy | $1K - $15K |
Read more about Abbott Laboratories (ABT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - Abbott Laboratories
The Market Cap of Abbott Laboratories is $187B.
As of today, Abbott Laboratories' PE (Price to Earnings) ratio is 28.88.
Currently, the price of one share of Abbott Laboratories stock is $108.27.
The ABT stock price chart above provides a comprehensive visual representation of Abbott Laboratories' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Abbott Laboratories shares. Our platform offers an up-to-date ABT stock price chart, along with technical data analysis and alternative data insights.
Yes, Abbott Laboratories (ABT) offers dividends to its shareholders, with a dividend yield of 2.21%. This dividend yield represents Abbott Laboratories' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Abbott Laboratories in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of Abbott Laboratories are HCA Healthcare, Cardinal Health, Henry Schein, Idexx Laboratories, and LabCorp.
